Fidelity SPDR Advertisement
Home > Boards > US Listed > Medical - Drugs > Nektar Therapeutics (NKTR)

Bad link... try this one for AMLN [#msg-10433899]

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
SeriousMoney Member Profile
 
Followed By 30
Posts 7,965
Boards Moderated 5
Alias Born 04/05/05
160x600 placeholder
Nektar Presents Data on Target-Specific Biomarkers from Circulating Tumor Cell Sub-Study of Phase 3 BEACON Study of Etirinote... "PR Newswire (US)" - 12/11/2014 6:00:00 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 12/11/2014 5:21:32 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 12/11/2014 5:18:59 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 12/11/2014 5:17:14 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 12/11/2014 5:15:05 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 12/11/2014 5:12:53 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 12/11/2014 5:10:43 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 12/11/2014 5:08:16 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 12/11/2014 5:02:45 PM
MOVENTIG® Approved In The European Union For Opioid-Induced Constipation "PR Newswire (US)" - 12/9/2014 8:00:00 AM
Baxter Submits Application For US FDA Approval Of BAX 855, Extended Half-Life Recombinant FVIII Based On ADVATE For Hemophili... "PR Newswire (US)" - 12/1/2014 9:18:00 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 11/26/2014 5:47:47 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 11/26/2014 5:41:50 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 11/26/2014 5:39:49 PM
FDA Grants QIDP Designation to Bayer's Amikacin Inhale and Ciprofloxacin Dry Powder for Inhalation "PR Newswire (US)" - 11/24/2014 10:12:00 AM
Nektar Presents Preclinical Study Findings for Etirinotecan Pegol (NKTR-102) in Combination with a PARP Inhibitor in BRCA1-de... "PR Newswire (US)" - 11/20/2014 9:00:00 AM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 11/7/2014 6:08:45 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 11/6/2014 4:20:41 PM
Nektar Therapeutics Reports Financial Results for the Third Quarter of 2014 "PR Newswire (US)" - 11/6/2014 4:10:00 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 11/4/2014 1:41:32 PM
Nektar to Announce Financial Results for the Third Quarter 2014 on Thursday, November 6, 2014, After Close of U.S.-Based Fina... "PR Newswire (US)" - 10/30/2014 8:30:00 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 9/26/2014 11:49:58 AM
Nektar Therapeutics Announces MOVENTIG® (naloxegol) Receives Positive CHMP Opinion In EU For Treatment Of Adults With Opioid... "PR Newswire (US)" - 9/26/2014 7:30:00 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 9/25/2014 3:56:03 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 9/25/2014 3:55:45 PM
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist